This Faculty Process Safety Workshop, sponsored by Dow, will show chemical engineering faculty how process safety is put into industrial practice and demonstrated the importance of process safety to the design and operation of a chemical plant.
Cleo Salisbury is a technical development team leader at Genentech, where she has led a variety of CMC programs ranging from ophtha to immuno-oncology, early to late stage development, traditional mAbs to ADCs, conjugates, and more. Prior to joining Genentech in 2013, Cleo was a research scientist at Novartis Diagnostics. She obtained her Ph.D. in Chemistry from UC Berkeley and did a postdoctoral fellowship with Ben Cravatt at the Scripps Research Institute. She is passionate about delivering new medicines to patients, nerdy science, daily...Read more
Dr. Bolton is a An Executive Director at Amgen, where he leads late-stage cell culture and purification development.
Prior to joining Amgen, Glen worked with different organizations including Millipore, Pfizer/Wyeth, and Biogen. Glen has served as Division Chair, Conference Chair and Treasurer for the ACS Biochemical Technology Division. He also taught the Protein Purification and Cell and Microbe Cultivation courses at Tufts.
In his current role as SVP Technical Development at BioMarin, Ganesh Vedantham is responsible for strategic and technical oversight of Process & Product Development, Clinical Manufacturing, and CMC Lifecycle Management. Previously, Ganesh spent more than two decades at Amgen/Immunex in increasingly senior roles across the organization in various sites. He is known for demonstrating strategic vision, the ability to build and lead diverse and high-performing teams, and encouraging open, collaborative, supportive, and driven cultures. Ganesh earned a Ph.D....Read more
Dr. Hernandez-Lopez is an Assistant Professor in the Departments of Bioengineering and of Genetics at Stanford University and a Chan-Zuckerberg Biohub Investigator. Rogelio received his Ph.D. in Chemical Physics at Harvard University and did postdoctoral research at UCSF. His lab focuses on engineering novel cellular therapies for cancer treatment.
On January 18th, the Future of STEM Scholars Initiative (FOSSI) hosted its first on-campus visit with 42 FOSSI scholars and 15 corporate sponsors at Howard University campus for lunch and a networking session. This was the first opportunity for in-person interaction between scholars and sponsors, who are eager to attend more of these gatherings in the future.
